PMV Pharmaceuticals, Inc.
USD1.16
-0.02 (-1.69%)
CEO
David H. Mack
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.18
Prev. Close
$1.18
Day Low
$1.15
Day High
$1.18
52W Low
$0.91
52W High
$1.88
Market Cap
$0.06B
Volume
0.27M
| 319,270 |
| $1.53 |
| 9 Mar 2026 | Jalota Deepika | Chief Development Officer | A-Award | Acquired | 303,310 | $1.53 |
| 9 Mar 2026 | Mack David Henry | director, officer: President and CEO | A-Award | Acquired | 744,960 | $1.53 |
| 29 Oct 2025 | Mack David Henry | director, officer: President and CEO | M-Exempt | Acquired | 220,643 | $1.37 |
| 29 Oct 2025 | Mack David Henry | director, officer: President and CEO | M-Exempt | Disposed | 220,643 | $1.37 |
| 27 Oct 2025 | ORBIMED ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 1,000,000 | $1.52 |
| 12 Sept 2025 | ORBIMED ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 500,000 | $1.80 |
| 3 Jul 2025 | Ticktin Robert | General Counsel & COO | S-Sale | Disposed | 23,151 | $1.06 |
| 3 Jul 2025 | Jalota Deepika | Chief Development Officer | S-Sale | Disposed | 33,065 | $1.06 |